Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?

Detalles Bibliográficos
Autores principales: Güner, Ahmet, Kalçık, Macit, Kalkan, Semih, Özkan, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Cardiovascular Society. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874973/
https://www.ncbi.nlm.nih.gov/pubmed/33581192
http://dx.doi.org/10.1016/j.cjca.2021.01.026
_version_ 1783649697023393792
author Güner, Ahmet
Kalçık, Macit
Kalkan, Semih
Özkan, Mehmet
author_facet Güner, Ahmet
Kalçık, Macit
Kalkan, Semih
Özkan, Mehmet
author_sort Güner, Ahmet
collection PubMed
description
format Online
Article
Text
id pubmed-7874973
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Canadian Cardiovascular Society. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78749732021-02-11 Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation? Güner, Ahmet Kalçık, Macit Kalkan, Semih Özkan, Mehmet Can J Cardiol Letter to the Editor Canadian Cardiovascular Society. Published by Elsevier Inc. 2021-06 2021-02-10 /pmc/articles/PMC7874973/ /pubmed/33581192 http://dx.doi.org/10.1016/j.cjca.2021.01.026 Text en © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Güner, Ahmet
Kalçık, Macit
Kalkan, Semih
Özkan, Mehmet
Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title_full Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title_fullStr Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title_full_unstemmed Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title_short Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
title_sort management of obstructive prosthetic heart valve thrombosis: thrombolytic therapy or anticoagulation?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874973/
https://www.ncbi.nlm.nih.gov/pubmed/33581192
http://dx.doi.org/10.1016/j.cjca.2021.01.026
work_keys_str_mv AT gunerahmet managementofobstructiveprostheticheartvalvethrombosisthrombolytictherapyoranticoagulation
AT kalcıkmacit managementofobstructiveprostheticheartvalvethrombosisthrombolytictherapyoranticoagulation
AT kalkansemih managementofobstructiveprostheticheartvalvethrombosisthrombolytictherapyoranticoagulation
AT ozkanmehmet managementofobstructiveprostheticheartvalvethrombosisthrombolytictherapyoranticoagulation

Ejemplares similares